We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+35.4%
1 Year Est. Return
+158.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$268M
AUM Growth
+$45.6M
Cap. Flow
+$18.2M
Cap. Flow %
6.78%
Top 10 Hldgs %
33.7%
Holding
508
New
146
Increased
78
Reduced
73
Closed
186

Top Buys

1
TSEM icon
Tower Semiconductor
TSEM
+$9.09M
2
LITE icon
Lumentum
LITE
+$8.24M
3
GLW icon
Corning
GLW
+$6.49M
4
INTC icon
Intel
INTC
+$5.94M
5
ALAB icon
Astera Labs
ALAB
+$4.77M

Top Sells

1
CNC icon
Centene
CNC
+$9.07M
2
MOH icon
Molina Healthcare
MOH
+$8.9M
3
ELV icon
Elevance Health
ELV
+$8.08M
4
BTSG icon
BrightSpring Health Services
BTSG
+$3.52M
5
TERN
Terns Pharmaceuticals
TERN
+$2.78M

Sector Composition

1 Technology 44.62%
2 Healthcare 29.67%
3 Financials 9.04%
4 Consumer Discretionary 3.92%
5 Energy 3.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KPTI icon
301
CALL
Karyopharm Therapeutics
KPTI
$216M
$2.11K ﹤0.01%
+610
New +$4.65K
APP icon
302
PUT
Applovin
APP
$143B
$2.02K ﹤0.01%
+1
New +$483
SNDK
303
PUT
Sandisk
SNDK
$201B
$1.97K ﹤0.01%
+2
New +$1.13K
KOD icon
304
CALL
Kodiak Sciences
KOD
$2.67B
$1.84K ﹤0.01%
1
-79
-99% -$2.04K
CRWV
305
PUT
CoreWeave
CRWV
$39.9B
$1.25K ﹤0.01%
+25
New +$2.17K
WFC icon
306
PUT
Wells Fargo
WFC
$265B
$1.21K ﹤0.01%
+33
New +$2.83K
OLMA icon
307
CALL
Olema Pharmaceuticals
OLMA
$1B
$1.15K ﹤0.01%
211
-49
-19% -$1.09K
NTLA icon
308
CALL
Intellia Therapeutics
NTLA
$1.59B
$632 ﹤0.01%
540
-30
-5% -$382
SLV icon
309
PUT
iShares Silver Trust
SLV
$27.1B
$504 ﹤0.01%
+28
New +$2.13K
AVXL icon
310
CALL
Anavex Life Sciences
AVXL
$221M
$412 ﹤0.01%
1,150
+828
+257% +$3.59K
CCL icon
311
PUT
Carnival Corporation Ltd
CCL
$36.2B
$378 ﹤0.01%
+54
New +$1.57K
JBIO
312
PUT
Jade Biosciences
JBIO
$1.27B
$344 ﹤0.01%
88
– –
VG
313
CALL
Venture Global Inc
VG
$34.3B
$338 ﹤0.01%
+27
New +$290
CVX icon
314
Chevron
CVX
$373B
$211 ﹤0.01%
+1
New +$182
IWM icon
315
PUT
iShares Russell 2000 ETF
IWM
$82.2B
$196 ﹤0.01%
+23
New +$5.93K
ABR icon
316
CALL
Arbor Realty Trust
ABR
$996M
$154 ﹤0.01%
335
– –
IOVA icon
317
PUT
Iovance Biotherapeutics
IOVA
$2.23B
$127 ﹤0.01%
+7
New +$22
ATYR
318
CALL
aTyr Pharma
ATYR
$50M
$122 ﹤0.01%
28
-8
-22% -$7
AAPL icon
319
PUT
Apple
AAPL
$4.9T
$23 ﹤0.01%
+1
New +$260
CRVS icon
320
CALL
Corvus Pharmaceuticals
CRVS
$1.25B
$11 ﹤0.01%
+270
New +$4.31K
EOLS icon
321
CALL
Evolus
EOLS
$377M
$10 ﹤0.01%
318
– –
AA icon
322
Alcoa
AA
$11.6B
– –
-12,525
Closed -$666K
AAOI icon
323
Applied Optoelectronics
AAOI
$8.22B
– –
-6,797
Closed -$237K
ABUS icon
324
CALL
Arbutus Biopharma
ABUS
$901M
– –
-1,484
Closed -$191K
ACRS icon
325
Aclaris Therapeutics
ACRS
$793M
– –
-22,259
Closed -$67K
11 12
13
14 15

Similar funds

VC
VarCov Co Darien, Connecticut $268M AUM
AL
AIP LLC New York $268M AUM 40.4% 1-Year Est. Return
FC
Foursixthree Capital New York $268M AUM 115.24% 1-Year Est. Return
NF
Nvest Financial Portsmouth, New Hampshire $268M AUM 22.87% 1-Year Est. Return
PF
Prosperitas Financial Valencia, California $268M AUM 32.64% 1-Year Est. Return
UI
Untitled Investments New York $269M AUM 11.35% 1-Year Est. Return
SSWM
Strait & Sound Wealth Management San Francisco, California $269M AUM 22.03% 1-Year Est. Return
AC
Applied Capital Little Rock, Arkansas $268M AUM 16.92% 1-Year Est. Return

Persistent Asset Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Persistent Asset Partners held 508 positions worth $268M, up 20% from $223M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Persistent Asset Partners deployed $18.2M of net new capital in Q1 2026, opening 146 new positions and adding to 78 existing holdings. Its largest new stake was Tower Semiconductor: 67,608 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Terns Pharmaceuticals, an estimated $2.78M trimmed.

  • Persistent Asset Partners's largest Q1 2026 buy was Tower Semiconductor: 67,608 shares worth $11.9M.
  • Persistent Asset Partners added most to Lumentum in Q1 2026, an estimated $8.24M increase.
  • Persistent Asset Partners's biggest Q1 2026 reduction was Terns Pharmaceuticals, cutting an estimated $2.78M.
  • Persistent Asset Partners fully exited Centene in Q1 2026, selling an estimated $9.07M.
  • Persistent Asset Partners's ten largest holdings make up 34% of its $268M portfolio in Q1 2026.
  • Persistent Asset Partners opened 146 new positions and closed 186 in Q1 2026.
  • Persistent Asset Partners's portfolio value rose 20% quarter-over-quarter to $268M.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.